Skip to search formSkip to main contentSkip to account menu

S 25930

Known as: S-25930 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ibafloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients.
The in-vitro activity of PD 117558, a new quinolone antimicrobial agent, was compared to that of four other quinolones, imipenem… 
1988
1988
Comparative in vitro activity of the two new 4-quinolones S-25930 and S-25932 against gram-positive bacteria isolated from cancer patients
The in vitro activity of S-25930 and S-25932, two new quinolone antimicrobial agents, against 306 gram-positive organisms… 
1987
1987
Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers
The mechanism of action of the quinolone analogs ofloxacin and S-25930, which are unusual because of the presence of a third ring… 
1987
1987
In-vitro activity of two new quinolone antimicrobial agents, S-25930 and S-25932 compared with that of other agents.
S-25930 and S-25932, two new 4-quinolones, were compared to ciprofloxacin, enoxacin, ofloxacin, norfloxacin, cefotaxime… 
1987
1987
In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients
The in vitro activity of S-25930 and S-25932, two new 4-quinolones, against 450 aerobic gram-negative organisms isolated from… 
1986
1986
In vitro studies of S-25930 and S-25932, two new 4-quinolones
The in vitro activity of S-25930 and S-25932 was compared with that of ciprofloxacin, norfloxacin and nalidixic acid against 740… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)